10X Genomics
TXG
$23.98
+7.58%
TXG price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on 10X Genomics's 12-month outlook, with a consensus price target around $31.17 and implied upside of +30.0% versus the current price.
Average Target
$31.17
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$19 - $31
Analyst target range
TXG Technical Analysis
Beta
2.05
2.05x market volatility
Max Drawdown
-28.0%
Largest decline past year
52-Week Range
$8-$26
Price range past year
Annual Return
+164.1%
Cumulative gain past year
| Period | TXG Return | S&P 500 |
|---|---|---|
| 1m | -2.5% | +4.6% |
| 3m | +25.0% | +8.3% |
| 6m | +30.8% | +12.5% |
| 1y | +164.1% | +25.0% |
| ytd | +44.3% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is TXG Overvalued?
PE
-46.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-15.5x
Enterprise Value Multiple